What is she best known for?
The fields of study she is best known for:
- Cancer
- Internal medicine
- Gene
Her main research concerns Pathology, Carcinoma, Immunohistochemistry, Stromal cell and Internal medicine.
Her Ovary research extends to Pathology, which is thematically connected.
Her Carcinoma research is multidisciplinary, incorporating elements of Transitional cell carcinoma, Ovarian carcinoma, Metastasis, Renal cell carcinoma and Adenocarcinoma.
In the subject of general Immunohistochemistry, her work in Immunostaining is often linked to GATA3, thereby combining diverse domains of study.
Her studies deal with areas such as CD34, Stroma and Atypia as well as Stromal cell.
Her Internal medicine research includes elements of Gastroenterology, Endocrinology and Oncology.
Her most cited work include:
- The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma (2002 citations)
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study (1555 citations)
- Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases (329 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Pathology, Internal medicine, Carcinoma, Immunohistochemistry and Oncology.
The study incorporates disciplines such as Uterus and Ovary in addition to Pathology.
In most of her Internal medicine studies, her work intersects topics such as Gastroenterology.
In her work, Serous carcinoma is strongly intertwined with Serous fluid, which is a subfield of Carcinoma.
Her study connects Staining and Immunohistochemistry.
Her International Prognostic Scoring System study in the realm of Myelodysplastic syndromes interacts with subjects such as In patient.
She most often published in these fields:
- Pathology (51.26%)
- Internal medicine (27.20%)
- Carcinoma (16.95%)
What were the highlights of her more recent work (between 2018-2021)?
- Pathology (51.26%)
- Internal medicine (27.20%)
- Carcinoma (16.95%)
In recent papers she was focusing on the following fields of study:
Esther Oliva spends much of her time researching Pathology, Internal medicine, Carcinoma, Myelodysplastic syndromes and Oncology.
The Pathology study combines topics in areas such as Endometrial cancer and General surgery.
Her Internal medicine research focuses on Gastroenterology and how it relates to Tumor size.
The various areas that she examines in her Carcinoma study include Endometrial Carcinomas, Lymphovascular, Stromal Invasion and Adenosquamous carcinoma.
Her Myelodysplastic syndromes research is multidisciplinary, relying on both Lower risk, Anemia and Intensive care medicine.
Her specific area of interest is Oncology, where Esther Oliva studies Grading.
Between 2018 and 2021, her most popular works were:
- Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists. (59 citations)
- High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations (55 citations)
- Clinicopathological and molecular characterisation of 'multiple-classifier' endometrial carcinomas. (47 citations)
In her most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Esther Oliva mainly focuses on Pathology, Carcinoma, Endometrial cancer, Internal medicine and Oncology.
Esther Oliva integrates many fields, such as Pathology and PAX8, in her works.
Her work deals with themes such as Biopsy, Disease, General surgery and Adenosquamous carcinoma, which intersect with Carcinoma.
Her Endometrial cancer research is multidisciplinary, incorporating perspectives in Hormone therapy, Serous carcinoma, Family medicine and Carcinosarcoma.
The concepts of her Oncology study are interwoven with issues in Ovarian carcinoma, Incidence and Lynch syndrome, DNA mismatch repair.
Her study explores the link between Differential diagnosis and topics such as Mitotic index that cross with problems in Immunohistochemistry.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
